Thermo Fisher Scientific, Inc. has entered a strategic partnership with Megaware, a life science technology organization, to deliver a new bioanalysis/equivalence solution and joint support services for pharma, biopharma and CROs. Under the terms of the collaboration, the two companies will market a new end-to-end software solution that provides bioequivalence functionality on a single platform in an effort to hasten and manage clinical trials. Market growth in generic drug production has c...